Cerevel Therapeutics
Developing CNS therapies
- B2B
About Cerevel Therapeutics
Biopharmaceutical company developing therapies for central nervous system disorders, with a portfolio targeting Parkinson's, Alzheimer's, epilepsy, schizophrenia, and addiction
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2018
- Revenue
- $53.7M – $425MTamtam estimate
- Website
- cerevel.com
- linkedin.com/company/cerevel
Cerevel Therapeutics at a glance
Cerevel Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Cambridge, Massachusetts, United States.
Cerevel Therapeutics was founded in 2018.
Cerevel Therapeutics has 251–1,000 employees.
Cerevel Therapeutics's revenue is $53.7M – $425M (Tamtam estimate).
Frequently asked questions about Cerevel Therapeutics
What is Cerevel Therapeutics's revenue?
Tamtam estimates Cerevel Therapeutics's annual revenue at $53.7M – $425M.
How many employees does Cerevel Therapeutics have?
Cerevel Therapeutics has 251–1,000 employees.
Where is Cerevel Therapeutics headquartered?
Cerevel Therapeutics is headquartered in Cambridge, Massachusetts, United States.
Selling to companies like Cerevel Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies